NON-SEGMENTAL VITILIGO
Clinical trials for NON-SEGMENTAL VITILIGO explained in plain language.
Never miss a new study
Get alerted when new NON-SEGMENTAL VITILIGO trials appear
Sign up with your email to follow new studies for NON-SEGMENTAL VITILIGO, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New antibody drug aims to restore skin color in vitiligo patients
Disease control Recruiting nowThis study tests a new drug called EI-001 in 45 adults with nonsegmental vitiligo, a condition that causes white patches on the skin. The drug works by calming the immune system to reduce inflammation that leads to pigment loss. Participants will receive either EI-001 or a placeb…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Elixiron Immunotherapeutics (Hong Kong) Ltd. • Aim: Disease control
Last updated May 26, 2026 03:50 UTC
-
Poking holes for pigment: can needling beat vitiligo?
Disease control Recruiting nowThis study tests two similar procedures—needling and microneedling—both followed by narrowband UVB light therapy, to see which works better at bringing back skin color in people with stable non-segmental vitiligo. Eighty adults aged 15 to 60 who have had vitiligo for over a year …
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE4 • Sponsor: Khyber Teaching Hospital • Aim: Disease control
Last updated May 26, 2026 03:50 UTC
-
New combo therapy shows promise for vitiligo in early trial
Disease control Recruiting nowThis study tests a new medicine called SHR0302, given as a pill alone or with a gel, for people with non-segmental vitiligo (white patches on skin). The goal is to see if it can bring back skin color safely. About 176 adults aged 18-75 will take part. The study is in phase 2, mea…
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Jiangsu HengRui Medicine Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 03:47 UTC
-
New pill could help restore skin color in vitiligo patients
Disease control Recruiting nowThis study tests a new tablet called VC005 for people with non-segmental vitiligo, a condition that causes white patches on the skin. The goal is to see if the drug can reduce the size of these patches on the face over 24 weeks. About 120 adults aged 18 to 70 will take part, and …
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Jiangsu vcare pharmaceutical technology co., LTD • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
New hope for vitiligo: experimental drug enters Mid-Stage trial
Disease control Recruiting nowThis study tests an experimental drug called GIA632 for adults with non-segmental vitiligo, a condition that causes white patches on the skin. About 210 participants will receive either the drug or a placebo to see if it can help restore skin color and to find the best dose. The …
Matched conditions: NON-SEGMENTAL VITILIGO
Phase: PHASE2 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 14:01 UTC